Boardminder

    George D. Yancopoulos, M.D., Ph.D.

    1 board
    Healthcare
    As of 8/31/2026

    0.38

    Boardminder Score™

    Top 16% of 4,262 directors

    Lower scoreHigher score

    25.7

    Avg Tenure (yrs)

    Shorter tenure than 3% of directors

    ShorterLonger

    —

    Total Compensation

    Board Seats Breakdown
    Regeneron Pharmaceuticals, Inc.
    REGN
    F500 #309
    Board co-Chair, President and Chief Scientific Officer
    Healthcare
    Seat Score
    0.38
    Tenure
    25.7 yrs
    Compensation
    —
    Excess Return
    -64.7%